Norfloxacin resistance mechanism of E. coli 11 and E. coli 101-clinical isolates of Escherichia coli in Korea

Archives of Pharmacal Research

Volumn 19, Issue 5, 1996, Pages 353-358

  Kim, Kyungsoon ^a   Lee, Soondeuk ^a   Lee, Yeonhee ^a  

^a Seoul Women University   (South Korea)

Author keywords

Antibacterial agents; Clinical isolate; Escherichia coli; Norfloxacin; Quinolone; Resistance

Indexed keywords

EID: 0000346237     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02976378     Document Type: Article

References (12)

1. Aoyama, H., Sato, K., Kato, T., Hirai, K. and Mitsuhashi, S., Norfloxacin resistance in a clinical isolate of Escherichia coli. Antimicrob. Agents Chemother., 31, 1640-1641 (1987).
2. Cambau, E., Bordon, F., Collatz, E. and Gutmann, L., Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid. Antimicrob. Agents Chemother., 37, 1247-1252 (1993).
3. Champman, J. S. and Georgopapadakou, N. H., Routes of quinolone permeation in Escherichia coli. Antimicrob. Agents Chemother., 32, 438-442 (1988).
4. Cullen, M. E., Wyke, A. W., Kuroda, R. and Fisher, L. M., Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones. Antimicrob. Agents Chemother., 33, 886-894 (1989).
5. Hallett, P. and Maxwell, A., Novel quinolone resistance mutations of the Escherichia coli DNA gyrase A protein : enzymatic analysis of the mutant proteins. Antimicrob. Agents Chemother., 35, 335-340 (1991).
6. Heisig, P., Schedletzky, H. and Falkenstein-Paul, H., Mutations in the gyrA gene of a highly fluoroquinolone resistant clinical isolate of Escherichia coli. Antimicrob. Agents Chemother., 37, 696-701 (1993).
7. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 660 (1970).
8. Lee, Y., Kim, K., Pyun, H., Park, W., Park, M. H. and Kim, W. J., Characterization of ciprofloxacin, HK-3140, norfloxacin, ofloxacin resistant strain of Escherichia coli. Korean Biochem. J., 25, 134-140 (1992).
9. Lee, Y., Lee, S., Park, M., Lee, T., Ha, J., Kong, J. and Kim, W. J., The resistant mechanism of Escherichia coli to a new fluoroquinolone-HK 3140. Korean Biochem. J., 26, 299-303 (1993).
10. Li, X., H. Nikaido and Poole, K., Role of MexA-MexB-OprM in antibiotic Efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 39, 1948-1953 (1995).
11. Yoshida, H., Kojima, T., Yamagishi, J. and Nakamura, S., Quinolone-resistant mutations of the gyrA gene of Escherichia coli. Mol. Gen. Genet., 211, 1-7 (1988).
12. Yoshida, H., Bogaki, M., Nakamura, M. and Nakamura, S., Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother., 34, 1271-1272 (1990).